Jump to main content
Jump to site search


Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

Author affiliations

Abstract

Here, we show a designed solid-state nanopore sensor for the direct sensing and quantification of prostate-specific antigen (PSA) as cancer biomarker in serum without any pretreatment. This nanopore technique provides a convenient, fast, and low-cost quantification of cancer biomarkers in clinical samples.

Graphical abstract: Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 Aug 2017, accepted on 27 Sep 2017 and first published on 27 Sep 2017


Article type: Communication
DOI: 10.1039/C7CC06775E
Citation: Chem. Commun., 2017, Advance Article
  •   Request permissions

    Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

    Y. Lin, Y. Ying, X. Shi, S. Liu and Y. Long, Chem. Commun., 2017, Advance Article , DOI: 10.1039/C7CC06775E

Search articles by author

Spotlight

Advertisements